BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 451397)

  • 1. [Dantrolene in juvenile spasticity: 3 months of daily observation].
    Berruti P
    Riv Neurol; 1979; 49(1):30-52. PubMed ID: 451397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of dantrolene sodium in the treatment of spasticity.
    Chipman M; Kaul S; Lambie M
    Dis Nerv Syst; 1974 Sep; 35(9):427-31. PubMed ID: 17894068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Dantrium on spasticity in paraplegic and tetraplegic patients (author's transl)].
    van Laere M; Leus P; Mastelinck C
    J Belge Med Phys Rehabil; 1978; 1(2):189-99. PubMed ID: 757420
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study of dantrolene sodium in the treatment of spastic and dystonic syndromes].
    Fraioli B; Guglielmi G; Baldassarre L
    Riv Neurol; 1976; 46(4):333-50. PubMed ID: 1023344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of dantrolene sodium on pyramidal hypertonia. Clinico-electrophysiological study].
    Caruso G; Fels A; Santoro L; Perretti A
    Acta Neurol (Napoli); 1977; 32(6):872-83. PubMed ID: 343514
    [No Abstract]   [Full Text] [Related]  

  • 6. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Jan; 13(1):3-23. PubMed ID: 318989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dantrium on spasticity of hemiplegic patients.
    Jonsson B; Ladd H; Afzelius-Frisk I; Lindberg-Broman AM
    Acta Neurol Scand; 1975 May; 51(5):385-92. PubMed ID: 1130170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dantrolene sodium: long-term effects in patients with muscle spasticity.
    Joynt RL
    Arch Phys Med Rehabil; 1976 May; 57(5):212-7. PubMed ID: 776122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sodium dantrolene (dantrium) in the treatment of neurogenic muscular spasm].
    Couto B; Figuereido HB; Araújo Leitão RE; Alvarenga H; Gomes Marleide M; Melo Reis CH
    Neurol Neurocir Psiquiatr; 1976; 17(4):213-21. PubMed ID: 1018726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dantrolene sodium for treatment of spasticity.
    Med Lett Drugs Ther; 1974 Jul; 16(15):61-2. PubMed ID: 4843632
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of a muscle relaxant: dantrolene sodium (Dantrium).
    Dykes MH
    JAMA; 1975 Feb; 231(8):862-4. PubMed ID: 1089167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)].
    Gonsette RE; Capart T; Demonty L
    Acta Neurol Belg; 1978; 78(3):141-7. PubMed ID: 352084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dantrolene sodium in children with spasticity.
    Haslam RH; Walcher JR; Lietman PS; Kallman CH; Mellits ED
    Arch Phys Med Rehabil; 1974 Aug; 55(8):384-8. PubMed ID: 4604292
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of dantrolene sodium and diazepam in the treatment of spasticity.
    Glass A; Hannah A
    Paraplegia; 1974 Nov; 12(3):170-4. PubMed ID: 4616209
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of dantrolene sodium and diazepam in the treatment of spasticity.
    Schmidt RT; Lee RH; Spehlmann R
    J Neurol Neurosurg Psychiatry; 1976 Apr; 39(4):350-6. PubMed ID: 778344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dantrolene sodium: long-term effects in severe spasticity.
    Chyatte SB; Basmajian JV
    Arch Phys Med Rehabil; 1973 Jul; 54(7):311-5. PubMed ID: 4577936
    [No Abstract]   [Full Text] [Related]  

  • 17. Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease.
    Weiser R; Terenty T; Hudgson P; Weightman D
    Practitioner; 1978 Jul; 221(1321):123-7. PubMed ID: 366589
    [No Abstract]   [Full Text] [Related]  

  • 18. [Attenuating effect of a new pharmacological agent (Dantrolene sodium) on spasticity].
    Ladd HW; Gingras G; Boucher J; Kazdan N; Keenan R
    Union Med Can; 1973 May; 102(5):1087-92. PubMed ID: 4576244
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dantrolene in the treatment of spasticity].
    Korczyn AD; Galinsky D; Berginer VM; Goren C
    Harefuah; 1978 Jul; 95(1):10-1. PubMed ID: 359424
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of dantrolene sodium on spasticity associated with hemiplegia.
    Steinberg FU; Ferguson KL
    J Am Geriatr Soc; 1975 Feb; 23(2):70-3. PubMed ID: 1141624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.